Aminopropyl terminated Polydimethylsiloxane cSt 50-60, 1kg

3-(3-bromophenyl)-3'-chloro-4'-fluoropropiophenone, 97.0%, 1g

Boc-NH-PEG4-C2-Boc, 1g

1,4-Benzenediacrylic acid, 98.0%, 25g

3-Amino-4-nitrobenzoic acid, 97.0%, 10g

1,4-Bis((E)-2-(pyridin-4-yl)vinyl)benzene, 97%, 5g

Fluroxypyr 1-Methylheptyl Ester>98.0%(HPLC)(N)25g

2-(5-Methoxypyridin-2-yl)acetonitrile, 95.0%, 250mg

2-Naphthaleneacetamide, 6-methoxy-alpha-methyl-, (alphaS)-, 95.0%, 1g

4-Cyanobenzoic acid, 95.0%, 5g

D-allose, min. 99%, 50 mg, glass packaging

Microliter syringe GASTIGHT® series 1700 Point type 3, 50 µl, 1705 RNR, 1 piece

(R)-Methyl piperidine-3-carboxylate, 95.0%, 1g